Main
>
GENETIC DISEASES (*)
>
Tyrosinemia Type 1 *
>
Treatment
>
Co: SE. S. Nitisinone Cap.
>
(*) CA Approval Date: 2017. 11.27>
>
>oral suspension formulation
>oral suspension formulation's products
This section has no products